143 related articles for article (PubMed ID: 11128872)
1. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Ogawa K; Shichishima T; Nakamura N; Maruyama Y
Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
3. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
[TBL] [Abstract][Full Text] [Related]
5. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
Br J Haematol; 1992 Feb; 80(2):194-8. PubMed ID: 1550776
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
[TBL] [Abstract][Full Text] [Related]
7. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
Nagai T; Izumi T; Noborio K; Takatoku M; Ohtsuki T; Machii T; Komatsu N; Ozawa K
Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130
[TBL] [Abstract][Full Text] [Related]
9. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.
Psiachou-Leonard E; Bain BJ
Clin Lab Haematol; 1998 Jun; 20(3):195-7. PubMed ID: 9681239
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Triozzi PL; Avery KA; Grever MR; Kraut EH
J Interferon Res; 1990 Oct; 10(5):535-40. PubMed ID: 2273300
[TBL] [Abstract][Full Text] [Related]
12. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
Bouroncle BA; Grever MR; Kraut EH
Leukemia; 1987 Apr; 1(4):350-4. PubMed ID: 3499542
[TBL] [Abstract][Full Text] [Related]
15. Pentostatin in the treatment of advanced hairy cell leukemia.
Kraut EH; Bouroncle BA; Grever MR
J Clin Oncol; 1989 Feb; 7(2):168-72. PubMed ID: 2783731
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
Dalal BI; Freier L; Johnston JB; Merry CC; Israels LG
Cancer; 1989 Jan; 63(1):14-22. PubMed ID: 2783375
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
[TBL] [Abstract][Full Text] [Related]
18. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin induces durable remissions in hairy cell leukemia.
Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
[TBL] [Abstract][Full Text] [Related]
20. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
Shibata T; Hotta T
Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]